Search Results for " Altiratinib "
Altiratinib Related Products
Altiratinib is potent, selective inhibitor of certain receptor tyrosine kinases involved in cancer cell growth and survival. It is being developed primarily for the treatment of non-small cell lung cancer (NSCLC) and other cancers with specific genetic mutations. Altiratinib works by blocking the activity of these receptor tyrosine kinases, which are involved in the signaling pathways that control cell proliferation and survival.
SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Altiratinib, pharmacopeial and non-pharmacopeial Altiratinib impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Altiratinib impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.